Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

VNV Global AB (publ)

2. Date of Event Requiring Statement (MM/DD/YYYY) 12/30/2022

3. Issuer Name and Ticker or Trading Symbol

Babylon Holdings Ltd [BBLN]

(Last) (First) (Middle)

M?STER SAMUELSGATAN 1

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director ___X___ 10% Owner
_____ Officer (give title below) _____ Other (specify below)

(Street)

STOCKHOLM, V7 111 44

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A ordinary shares	3324819	I	See footnote ⁽¹⁾
Class A ordinary shares	709812	I	See footnote ⁽²⁾

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)

Explanation of Responses:
(1)	These Class A ordinary shares (the "Shares") are owned directly by VNV (Cyprus) Limited ("VNV Cyprus"). VNV Cyprus is a wholly-owned subsidiary of VNV Global AB (publ) ("VNV Global"). VNV Global may be deemed to beneficially own the Shares held by VNV Cyprus.
(2)	These Shares are owned directly by Global Health Equity (Cyprus) Ltd ("Global Health Equity"). VNV Global indirectly holds, through its direct wholly-owned subsidiary, VNV Sweden AB ("VNV Sweden"), approximately 37.3521% of the shares in Global Health Equity AB (publ) ("Global Health (publ)"), the direct and sole shareholder of Global Health Equity, with the remainder held by other foreign institutional investors and individuals. VNV Global may be deemed to beneficially own the Shares held by Global Health Equity.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
VNV Global AB (publ) M?STER SAMUELSGATAN 1 STOCKHOLM, V7 111 44		X
VNV (Cyprus) Ltd 1, LAMPOUSAS STREET NICOSIA, G4 1095		X

Signatures
/s/ Per Brilioth, Managing Director for VNV Global AB (publ)		12/30/2022
^**Signature of Reporting Person		Date
/s/ Chrystalla Dekatris, Director of VNV (Cyprus) Limited		12/30/2022
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.